ESR2 and ovarian carcinoma: Liquiritigenin, a natural ERβ agonist that has good antioxidant and anti-inflammatory effects, can significantly inhibit ovarian cancer cell viability, reduce migration and invasion, and promote apoptosis (36, 37).